Related Experiment Video
Updated: Aug 19, 2025
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.2K
Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic
Viranda H Jayalath1, Roderick Clark1,2,3, Katherine Lajkosz1
1Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
JAMA Network Open
|November 30, 2022
Summary
Statin use in advanced prostate cancer patients on androgen-ablative therapies was linked to lower mortality. This included reduced overall and prostate cancer-specific mortality, though evidence quality was low.
Area of Science:
- Oncology
- Pharmacology
- Epidemiology
Background:
- Advanced prostate cancer treatment often involves androgen-ablative therapies (ADT/ARATs).
- Epidemiological studies suggest statins may improve survival in these patients.
- The association between statin use and survival outcomes requires systematic evaluation.
Approach:
- A systematic review and meta-analysis of observational studies was conducted.
- Data from 25 cohorts (119,878 men) were synthesized.
- Multivariable hazard ratios were pooled using random-effects modeling.
Key Points:
- Concurrent statin use was associated with a 27% reduction in overall mortality (HR, 0.73) and a 35% reduction in prostate cancer-specific mortality (PCSM) (HR, 0.65).
- A significant PCSM advantage was observed for statin users receiving androgen receptor axis-targeted therapies (ARATs) compared to ADT alone (HR, 0.40 vs 0.68).
- Substantial heterogeneity was noted, and the GRADE assessment rated confidence in the evidence as low.
Conclusions:
- Statin use correlates with improved survival in advanced prostate cancer patients undergoing androgen-ablative therapies.
- The observational nature of the data and heterogeneity necessitate cautious interpretation.
- Randomized clinical trials are recommended to confirm these findings and establish causality.
Related Concept Videos
01:21Cancer Survival Analysis
413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:20Comparing the Survival Analysis of Two or More Groups
248
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
248
01:20Actuarial Approach
110
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
110
01:15Assumptions of Survival Analysis
173
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
173
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K